These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9860152)

  • 21. Carbamazepine-risperidone interactions in patients with epilepsy.
    Mula M; Monaco F
    Clin Neuropharmacol; 2002; 25(2):97-100. PubMed ID: 11981236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
    Macias WL; Bergstrom RF; Cerimele BJ; Kassahun K; Tatum DE; Callaghan JT
    Pharmacotherapy; 1998; 18(6):1237-48. PubMed ID: 9855322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
    Damkier P; Hansen LL; Brosen K
    Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
    Damkier P; Brøsen K
    Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monitoring of serum olanzapine during antipsychotic treatment].
    Linnet K; Olesen OV
    Ugeskr Laeger; 2000 Sep; 162(36):4802-5. PubMed ID: 10994377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia.
    Grothe DR; Calis KA; Jacobsen L; Kumra S; DeVane CL; Rapoport JL; Bergstrom RF; Kurtz DL
    J Clin Psychopharmacol; 2000 Apr; 20(2):220-5. PubMed ID: 10770461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine.
    Zullino DF; Delessert D; Eap CB; Preisig M; Baumann P
    Int Clin Psychopharmacol; 2002 May; 17(3):141-3. PubMed ID: 11981356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral olanzapine disposition in adolescents with schizophrenia or bipolar I disorder: a population pharmacokinetic model.
    Lobo ED; Robertson-Plouch C; Quinlan T; Hong Q; Bergstrom RF
    Paediatr Drugs; 2010 Jun; 12(3):201-11. PubMed ID: 20297865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Piperine on the Metabolism and Pharmacokinetics of Carbamazepine in Healthy Volunteers.
    Bedada SK; Appani R; Boga PK
    Drug Res (Stuttg); 2017 Jan; 67(1):46-51. PubMed ID: 27776366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential olanzapine plasma concentrations by sex in a fixed-dose study.
    Kelly DL; Conley RR; Tamminga CA
    Schizophr Res; 1999 Nov; 40(2):101-4. PubMed ID: 10593449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
    Koup JR; Anderson GD; Loi CM
    J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentration.
    Markowitz JS; DeVane CL
    J Clin Psychopharmacol; 1999 Jun; 19(3):289-91. PubMed ID: 10350045
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.
    Shirley KL; Hon YY; Penzak SR; Lam YW; Spratlin V; Jann MW
    Neuropsychopharmacology; 2003 May; 28(5):961-6. PubMed ID: 12644842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.
    Rosaria Muscatello M; Pacetti M; Cacciola M; La Torre D; Zoccali R; D'Arrigo C; Migliardi G; Spina E
    Epilepsia; 2005 May; 46(5):771-4. PubMed ID: 15857446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants.
    Gardiner SJ; Kristensen JH; Begg EJ; Hackett LP; Wilson DA; Ilett KF; Kohan R; Rampono J
    Am J Psychiatry; 2003 Aug; 160(8):1428-31. PubMed ID: 12900304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of resveratrol on the pharmacokinetics of carbamazepine in healthy human volunteers.
    Bedada SK; Nearati P
    Phytother Res; 2015 May; 29(5):701-6. PubMed ID: 25624269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine excretion in human breast milk: estimation of infant exposure.
    Croke S; Buist A; Hackett LP; Ilett KF; Norman TR; Burrows GD
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):243-7. PubMed ID: 12366877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine overdose.
    Fogel J; Díaz JE
    Ann Emerg Med; 1998 Aug; 32(2):275-6. PubMed ID: 9701324
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis and pharmacokinetics of olanzapine (LY170053) and two metabolites in rat plasma using reversed-phase HPLC with electrochemical detection.
    Chiu JA; Franklin RB
    J Pharm Biomed Anal; 1996 Mar; 14(5):609-15. PubMed ID: 8738191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of carbamazepine on the single oral dose pharmacokinetics of perospirone and its active metabolite.
    Masui T; Kusumi I; Takahashi Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1330-3. PubMed ID: 16600452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.